Efficacy and tolerability of immune checkpoint inhibitors in elderly patients with MSI/ dMMR gastrointestinal cancers and impact of toxicities on efficacy: The immunoMSI cohort.

被引：0
|
作者：
Mailly-Giacchetti, Leah
Colle, Raphael
Ataz, Daniel Lopez-Trabada
Duval, Alex
Andre, Thierry
Cohen, Romain
机构：
[1] Sorbonne Univ, St Antoine Hosp, AP HP, Dept Med Oncol, Paris, France
[2] St Antoine Hosp, Dept Med Oncol, Paris, France
[3] Sorbonne Univ, INSERM, Unite Mixte Rech Sci 938, Paris, France
[4] Ctr Rech St Antoinee, Site Rech Integree Canc SIRIC, CURAMUS, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
795
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [41] The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study
    Chen, Mifen
    Wang, Zhenghang
    Liu, Zimin
    Liu, Ning
    Fang, Weijia
    Zhang, Hangyu
    Jin, Xuan
    Li, Jiayi
    Zhao, Weifeng
    Qu, Huajun
    Song, Fanghua
    Chang, Zhiwei
    Li, Yi
    Tang, Yong
    Xu, Chunlei
    Zhang, Xiaotian
    Wang, Xicheng
    Peng, Zhi
    Cai, Jinping
    Li, Jian
    Shen, Lin
    CANCERS, 2022, 14 (20)
  • [42] The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis
    Yin, Jiaxin
    Song, Yuxiao
    Fu, Yang
    Jun, Wang
    Tang, Jiazhuo
    Zhang, Zhimin
    Song, Qibin
    Zhang, Bicheng
    AGING-US, 2023, 15 (24): : 15025 - 15049
  • [43] Impact of body mass index on the efficacy of immune checkpoint inhibitors in cancer
    Rios Hoyo, A.
    Hardy-Werbin, M.
    Monzonis, X.
    Monge Escartin, I.
    Moliner, L.
    Navarro, N.
    Taus, A.
    Duran, X.
    Conde, D.
    Arriola, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S837 - S837
  • [44] The Impact of driver gene alteration type on the efficacy of immune checkpoint inhibitors
    Tsuruoka, H.
    Mouri, A.
    Shukuya, T.
    Tsuda, T.
    Nagai, Y.
    Ashinuma, H.
    Kataoka, S.
    Tanaka, H.
    Takahashi, S.
    Yamanaka, Y.
    Soda, S.
    Shoji, T.
    Watanabe, S.
    Tsukita, Y.
    Tamura, Y.
    Hayashihara, K.
    Morita, S.
    Kobayashi, K.
    Maemondo, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1645 - S1646
  • [45] Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
    Takafumi Yanagisawa
    Tatsushi Kawada
    Fahad Quhal
    Kensuke Bekku
    Ekaterina Laukhtina
    Pawel Rajwa
    Markus von Deimling
    Muhammad Majdoub
    Marcin Chlosta
    Benjamin Pradere
    Keiichiro Mori
    Takahiro Kimura
    Manuela Schmidinger
    Pierre I. Karakiewicz
    Shahrokh F. Shariat
    World Journal of Urology, 2023, 41 : 1763 - 1774
  • [46] Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review
    Li, Honglin
    Zhang, Lei
    Yang, Feiran
    Zhao, Ruohan
    Li, Xiurong
    Li, Huijie
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Real-life efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient (dMMR/ MSI-H) biliary tract cancer (BTC)
    le Brun, I. Campo
    Grapinet, E.
    Hollebecque, A.
    Aurillac, V.
    Parent, P.
    Girot, P.
    Gendreau, M.
    Rafert, S.
    Javed, S.
    Touchefeu, Y.
    Roth, G.
    Muller, M.
    Lequoy, M.
    Boileve, A.
    Decraecker, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S125 - S125
  • [48] Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
    Yanagisawa, Takafumi
    Kawada, Tatsushi
    Quhal, Fahad
    Bekku, Kensuke
    Laukhtina, Ekaterina
    Rajwa, Pawel
    von Deimling, Markus
    Majdoub, Muhammad
    Chlosta, Marcin
    Pradere, Benjamin
    Mori, Keiichiro
    Kimura, Takahiro
    Schmidinger, Manuela
    Karakiewicz, Pierre I.
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1763 - 1774
  • [49] A review of the patterns of prescribing, efficacy and toxicities for patients receiving checkpoint inhibitors.
    Nightingale, Peter
    Parente, Phillip
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal versus gastric cancers: A large, multicenter, cohort study
    Mazzoli, G.
    Nichetti, F.
    Shitara, K.
    Cohen, R.
    Lonardi, S.
    Elez, E.
    Fakih, M.
    Klempner, S.
    Jayachandran, P.
    Maron, S.
    Fornaro, L.
    Salvatore, L.
    Valerie, Z.
    Aoki, Y.
    Ambrosini, M.
    Cremolini, C.
    Randon, G.
    Overman, M.
    Andre, T.
    Pietrantonio, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S11 - S12
12345